← SynDRA
DBeQ
SynDRA canonical compound SYN0062868 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CASP3 |
|---|
| Mechanism of action | ATPase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX12
- ATXN2
- CBX1
- EHMT2
- GLP1R
- GMNN
- HDAC6
- HPGD
- IDH1
- NPSR1
- POLH
- SMAD3
- TARDBP
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- N2,N4-Dibenzylquinazoline-2,4-diamine
- DBeQ cpd
- RefChem:164321
- DTXCID1020936
- N,N'-dibenzylquinazoline-2,4-diamine
- 2-N,4-N-dibenzylquinazoline-2,4-diamine
- MFCD03691820
- KUC105555N
- MLS000769571
- SMR002239188
- SMR000434303
- JRF12
- N*2*,N*4*-Dibenzyl-quinazoline-2,4-diamine
- JRF-12
- 2,4-Quinazolinediamine, N,N'-bis(phenylmethyl)-
- DBeQ?
- Oprea1_067556
- Oprea1_526582
- MLS003568133
- MLS006012041
- orb1306929
- orb1713954
- SCHEMBL12175837
- BDBM46584
- EX-A679
- CHEBI:231699
- cid_16472035
- DBeQ, >=98% (HPLC)
- GLXC-05945
- HMS3653I17
- CCG-24030
- EBC-79041
- KSC-16-67
- s7199
- STL367897
- AKOS001679884
- KUC105555N-02
- NCGC00347066-01
Look up DBeQ in the interactive SynDRA portal →